The management of submassive PE (intermediate risk PE) has been an area of controversy for years. With early evidence demonstrating potential benefit of thrombolysis in both short and long term outcomes. The flipside is the demonstrated increased risk of haemorrhage. Despite this more recent trials have emerged to somewhat quell the thrombo-enthusiasts however it is likely that we still don't have all the answers?